Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trident LifelineBOM:543616 +1.73%83 Return-on-Tangible-Asset is 9.30% as of Jun. 2026, which is 10% below its 10-year median of 10.32. GuruFocus rates BOM:543616 with a GF Score™ of 83/100 and a GF Value™ of ₹617.59 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 687 Healthcare Providers & Services companies, Trident Lifeline ranks better than 85.3% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Trident Lifeline's annualizedNet Income for the quarter that ended in Jun. 2026 was ₹201 Mil. Trident Lifeline's average total tangible assets for the quarter that ended in Jun. 2026 was ₹2,164 Mil. Therefore, Trident Lifeline's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 9.30%.
The historical rank and industry rank for Trident Lifeline's Return-on-Tangible-Asset or its related term are showing as below:
BOM:543616'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -13.56 Med: 10.32 Max: 33.83
Current: 11.71
During the past 7 years, Trident Lifeline's highest Return-on-Tangible-Asset was 33.83%. The lowest was -13.56%. And the median was 10.32%.
BOM:543616's Return-on-Tangible-Asset is ranked better than 85.3% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 2.59
vs BOM:543616: 11.71
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Trident Lifeline Return-on-Tangible-Asset Related Terms
Trident Lifeline Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Trident Lifeline's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Trident Lifeline's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trident Lifeline Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Trident Lifeline's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Trident Lifeline's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 9.30% mean?
Trident Lifeline (BOM:543616) has a Return-on-Tangible-Asset of 9.30% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Trident Lifeline and its competitors. This is 10% below median its historical median of 10.32. According to the industry distribution chart, Trident Lifeline ranks #101 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 14.7%.
Is Trident Lifeline's Return-on-Tangible-Asset too high?
Trident Lifeline's current Return-on-Tangible-Asset of 9.30% is 10% below median its 10-year median of 10.32. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.59. Trident Lifeline's value of 9.30% is 259.1% above this industry median. Based on the distribution chart, Trident Lifeline ranks #101 out of 687 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Trident Lifeline has a GF Score™ of 83/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trident Lifeline's Return-on-Tangible-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Trident Lifeline ranks #101 out of 687 companies for Return-on-Tangible-Asset. This places Trident Lifeline in the top 15% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.59. Trident Lifeline's value of 9.30% is 259.1% above this benchmark. While the company's 10-year median is 10.32 vs. the industry median of 2.59, Trident Lifeline has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.59, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trident Lifeline's current Return-on-Tangible-Asset of 9.30% is 259.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Trident Lifeline and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trident Lifeline's current Return-on-Tangible-Asset is 9.30%, which is 10% below median its own 10-year median of 10.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trident Lifeline stock overvalued right now?
Based on GuruFocus' analysis, Trident Lifeline (BOM:543616) is currently considered Possible Value Trap. The stock's GF Value™ is ₹617.59, compared to a current price of ₹302.50 — trading 51% below its estimated fair value. The current Return-on-Tangible-Asset is 9.30%, which is 10% below median its 10-year median of 10.32 and 259.1% above the Healthcare Providers & Services industry median of 2.59. Trident Lifeline's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Trident Lifeline (BOM:543616), the current Return-on-Tangible-Asset is 9.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trident Lifeline (BOM:543616) Overvalued in 2026?
Based on GuruFocus' analysis, Trident Lifeline stock appears to be undervalued.
The current stock price of ₹302.50 is trading 51% below its estimated GF Value™ of ₹617.59.
GuruFocus considers Trident Lifeline to be Possible Value Trap.
Key valuation signals for BOM:543616:
Return-on-Tangible-Asset: 9.30% (10% below median its 10-year median of 10.32)
GF Value™: ₹617.59 vs. price of ₹302.50 (51% below fair value)
Industry Position: 259.1% above the Healthcare Providers & Services median (#101 of 687)
No single metric tells the full story. See the BOM:543616 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trident Lifeline Ltd is engaged in the marketing of pharmaceutical products in domestic as well as international market. The company is also engaged in distribution of pharmaceutical products through third-party distribution network. It also offers a wide range of pharmaceutical formulations and products manufactured on contract manufacturing under a loan license. The Company's reportable geographical segments include India, Ghana, Kenya, Peru, Cameroon, Venezuela, and the Rest of World.
83GF Score
Get the complete analysis for BOM:543616
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543616 has been successfully added to your 
